Drug intelligence / Profile preview

Dimet

Development stage: Preclinical
Lead developer: Infectopharm
Administration: Topical

Overview

Dimet is a medical device containing dimeticone, a silicone-based polymer, used for the treatment of head lice infestation. Its mechanism of action is physical, working by coating and suffocating the head lice, rather than through chemical or pharmacological means. It is applied topically. A specific formulation, Dimet 5, contains 100% dimeticone.

Brand names: Dimet 5Dimet5Dimet-5
Other names: Dimeticon

Beyond the preview

Go deeper on Dimet.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dimet.

Explore the full profile